CN1459284A - Neohouttuynin sodium freeze-dried powder-injection, and its prepn. method - Google Patents
Neohouttuynin sodium freeze-dried powder-injection, and its prepn. method Download PDFInfo
- Publication number
- CN1459284A CN1459284A CN 03112411 CN03112411A CN1459284A CN 1459284 A CN1459284 A CN 1459284A CN 03112411 CN03112411 CN 03112411 CN 03112411 A CN03112411 A CN 03112411A CN 1459284 A CN1459284 A CN 1459284A
- Authority
- CN
- China
- Prior art keywords
- injection
- neo
- houttuyninum
- cyclodextrin
- dried powder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Abstract
A freeze-dried powder injection of neohouttuynine sodium for treating pelvic inflammation, annexitis and chronic cervicitis contains neohouttuynine sodium, one or more of cyclodextrin and its derivatives and excipient in a certain proportion. It is prepared through dissolving neohouttuynine sodium and cyclodextrin or its derivative in the water for injection, adding excipient, regulating the pH value, filtering, freezing, and sublimation drying.
Description
(1) technical field
The present invention relates to injection neo-houttuyninum sodium freeze-dried powder injection and preparation method thereof, belong to medical technical field.
(2) background technology
Neo-houttuyninum is artificial composite, chemical name lauroyl acetaldehyde sodium sulfite, this product is easily molten in hot water, slightly soluble in water, ethanol, almost insoluble in chloroform, benzene, easily molten in sodium hydroxide test solution, but decompose (the 5th P273 of national drug standards chemical drugs provincial standard rising national standard) simultaneously.And neo-houttuyninum has the fishy smell flavor, and little smelly, These characteristics makes its preparation and application be subjected to certain limitation.
The usage and dosage of the national drug standards (the 4th P323 of chemical drugs provincial standard rising national standard) new houttuynine sodium bisulfite injection description has been narrated new houttuynine sodium bisulfite injection and can be used for intramuscular injection or intravenous drip, in the points for attention of description, indicate: when low temperature, may separate out milky point or crystallization, in hot water, soak molten after, still can use.This has brought inconvenience for the clinical use of this medicine, the shortcoming of this medicine also has been described:, easily separate out simultaneously in instability storage period.
(3) summary of the invention
The present invention is directed to and remedy the deficiencies in the prior art, a kind of injection neo-houttuyninum sodium freeze-dried powder injection and preparation method thereof is provided.
Injection neo-houttuyninum sodium freeze-dried powder injection of the present invention comprises following component, all is weight percentage:
Neo-houttuyninum 0.01%～40%, in cyclodextrin or the cyclodextrin derivative one or more 0.01%～95%, excipient 0～97%.
Above-mentioned described neo-houttuyninum, content is greater than 98%, with high effective liquid chromatography for measuring.
Above-mentioned cyclodextrin or cyclodextrin derivative are: alpha-cyclodextrin, alpha-cyclodextrin derivant, beta-schardinger dextrin-, beta-cyclodextrin derivative, gamma-cyclodextrin or gamma-cyclodextrin derivant.Molecular weight gets final product by this area normal ranges.
Above-mentioned excipient is selected from one or more in mannitol, lactose, glycine, sorbitol, low molecular dextran, glucose, the hydrolysis gel.Molecular weight gets final product by this area normal ranges.
The preparation method of injection neo-houttuyninum sodium freeze-dried powder injection of the present invention comprises that step is as follows:
(1) gets neo-houttuyninum 0.01%～40%, in cyclodextrin or the cyclodextrin derivative one or more 0.01%～95%, close and place container, the water for injection that adds 200～4000 times of weight of neo-houttuyninum stirs into pasty state, add 70 ℃～85 ℃ waters for injection of 200～4000 times of weight of neo-houttuyninum again, be incubated 70 ℃～85 ℃ dissolvings;
(2) add excipient, dissolving, adjust pH to 4.0～7.0;
(3) solution filters, the filtrate packing;
(4) freezing, carry out sublimation drying, get white loose block or powder-product.
Can add adsorbent pin charcoal after above-mentioned steps (2), stirring at room adopts microporous filter membrane, titanium filter stick or sand filtration rod filtering decarbonization.
Filter employing 0.22～0.45 μ m microporous filter membrane fine straining at above-mentioned steps (3) solution, filtrate is carried out packing by every 0.5ml～10ml.
Freezing method in above-mentioned steps (4) is as follows: per minute reduces by 10 ℃～15 ℃, cools to-30 ℃ to-50 ℃ until solution, keeps 2 hours～8 hours, heats to-20 ℃ to-35 ℃ again.
Preparation finishes, and goods are taken out, and seals, and promptly obtaining character is the injection neo-houttuyninum sodium freeze-dried powder injection of white loose block or powder.
Compared with prior art, excellent results of the present invention is as follows:
1. adopted the cyclodextrin or derivatives thereof, because cyclodextrin, cyclodextrin derivative have special ring-type hollow cylinder type structure, so can with the neo-houttuyninum molecule forming bag mixture, thereby improved the dissolubility of medicine, covered the bad smell of medicine, strengthened stability of drug, reduced the zest of medicine, improved bioavailability of medicament the people.
2. the cyclodextrin or derivatives thereof also can for production procurement provides convenience, improve the productivity as excipient when playing clathration, and this is that general solubilizing agent is irreplaceable.
3. selected lyophilized injectable powder, there is not moisture, thereby improved stability of drug, guaranteed the quality of medicine, the phenomenon of low temperature crystallize can not occur, made clinical use safe ready more, clinical adverse and side effect have been reduced, prolonged the storage period of medicine simultaneously, and injection neo-houttuyninum sodium freeze-dried powder injection has and meets the quick-dissolving characteristics of water, for clinical use provides convenience.
Injection neo-houttuyninum sodium freeze-dried powder injection of the present invention all complies with relevant regulations in the check of items such as content, pyrogen, aseptic, pH, and no antigen has no side effect.And there is not bad abnormal smells from the patient.This product can be used for intramuscular injection or intravenous drip, is used for the treatment of gynecological inflammations such as pelvic inflammatory disease, adnexitis, chronic cervicitis.
(4) specific embodiment
Embodiment 1: injection neo-houttuyninum sodium freeze-dried powder injection, and component is as follows, all is weight percentage:
Neo-houttuyninum 2.0%
HP-22.6%
Mannitol 75.4%
Preparation method is as follows:
Get neo-houttuyninum sodium raw materials 12g, HP-135g, add injection water 3L, stir into pasty state, add 70 ℃～85 ℃ water for injection 3L again, temperature is controlled at 70 ℃～85 ℃ during dissolving, with mannitol 450g dissolving, reuse 1moL/L hydrochloric acid solution adjust pH to 5.6, add pin with charcoal after stirring at room, filtering decarbonization, fine straining.Filtrate is carried out packing by every 2ml, adopts quick freezing, and per minute reduces by 10 ℃, cools to-45 ℃ until solution, keeps 4 hours, heats to-20 ℃ again, carries out sublimation drying, and goods are taken out, and seals, and promptly obtaining character is white loose block or powder.
Embodiment 2: injection neo-houttuyninum sodium freeze-dried powder injection, and component is as follows, all is weight percentage:
Neo-houttuyninum 4.3%
Alpha-cyclodextrin 53.2%
Lactose 42.5%.
Preparation method is as follows:
Get neo-houttuyninum sodium raw materials 30g, alpha-cyclodextrin 375g, add injection water 3L, stir into pasty state, add 70 ℃～85 ℃ water for injection 3 L again, temperature is controlled at 70 ℃～85 ℃ during dissolving, add lactose 300g dissolving, reuse 1moL/L hydrochloric acid solution adjust pH to 4.8, add pin with charcoal after stirring at room, filtering decarbonization, fine straining.Filtrate is carried out packing by every 2ml, adopts quick freezing, and per minute reduces by 10 ℃, cools to-40 ℃ until solution, keeps 4 hours, heats to-20 ℃ again, carries out sublimation drying, and goods are taken out, and seals, and promptly obtaining character is white loose block or powder.
Embodiment 3: injection neo-houttuyninum sodium freeze-dried powder injection, and component is as follows, all is weight percentage:
Neo-houttuyninum 5.7%
Gamma-cyclodextrin 65.7%
Glucose 28.5%
Preparation method is as follows:
Get neo-houttuyninum sodium raw materials 60g, gamma-cyclodextrin 690g, add injection water 3L, stir into pasty state, add 70 ℃～85 ℃ water for injection 3L again, temperature is controlled at 70 ℃～85 ℃ during dissolving, add glucose 300g dissolving, reuse 1moL/L hydrochloric acid solution adjust pH to 6.2, add pin with charcoal after stirring at room, filtering decarbonization, fine straining.Filtrate is carried out packing by every 2ml, adopts quick freezing, and per minute reduces by 15 ℃, cools to-45 ℃ until solution, keeps 4 hours, heats to-30 ℃ again, carries out sublimation drying, and goods are taken out, and seals, and promptly obtaining character is white loose block or powder.
The foregoing description product effect is summarized as follows shown in the table.
| Sequence number | Specification | The dissolving situation |
| Embodiment 1 | 4mg | Every bottle adds 2ml water for injection, and jog 5 seconds is instant, the solution clarification. |
| Embodiment 2 | 10mg | Every bottle adds 5ml water for injection, and jog 5 seconds is instant, the solution clarification. |
| Embodiment 3 | 20mg | Every bottle adds 5ml water for injection, and jog 5 seconds is instant, the solution clarification. |
Embodiment 4: injection neo-houttuyninum sodium freeze-dried powder injection, and component is as follows, all is weight percentage:
Neo-houttuyninum 7.4%
HP-92.6%.
Preparation method is as follows:
Get neo-houttuyninum sodium raw materials 60g, HP-750g, add injection water 3L, stir into pasty state, add 70 ℃～85 ℃ water for injection 3L again, temperature is controlled at 70 ℃～85 ℃ during dissolving, reuse 1moL/L hydrochloric acid solution adjust pH to 5.4, add pin with charcoal after stirring at room, filtering decarbonization, fine straining.Filtrate is carried out packing by every 2ml, adopts quick freezing, and per minute reduces by 10 ℃, cools to-40 ℃ until solution, keeps 4 hours, heats to-20 ℃ again, carries out sublimation drying, and goods are taken out, and seals, and promptly obtaining character is white loose block or powder.
Claims (7)
1. injection neo-houttuyninum sodium freeze-dried powder injection is characterized in that, comprises following component, all is weight percentage:
Neo-houttuyninum 0.01%～40%, in cyclodextrin or the cyclodextrin derivative one or more 0.01%～95%, excipient 0～97%.
2. injection neo-houttuyninum sodium freeze-dried powder injection as claimed in claim 1, it is characterized in that described cyclodextrin or cyclodextrin derivative are: alpha-cyclodextrin, alpha-cyclodextrin derivant, beta-schardinger dextrin-, beta-cyclodextrin derivative, gamma-cyclodextrin or gamma-cyclodextrin derivant.
3. injection neo-houttuyninum sodium freeze-dried powder injection as claimed in claim 1 is characterized in that described excipient is selected from one or more in mannitol, lactose, glycine, sorbitol, low molecular dextran, glucose, the hydrolysis gel.
4. the described injection neo-houttuyninum of claim 1 sodium freeze-dried powder injection preparation method, step is as follows:
(1) gets neo-houttuyninum 0.01%～40%, in cyclodextrin or the cyclodextrin derivative one or more 0.01%～95%, close and place container, the water for injection that adds 200～4000 times of weight of neo-houttuyninum stirs into pasty state, add 70 ℃～85 ℃ waters for injection of 200～4000 times of weight of neo-houttuyninum again, be incubated 70 ℃～85 ℃ dissolvings;
(2) add excipient, dissolving, adjust pH to 4.0～7.0;
(3) solution filters, the filtrate packing;
(4) freezing, carry out sublimation drying, get white loose block or powder-product.
5. injection neo-houttuyninum sodium freeze-dried powder injection preparation method as claimed in claim 4 is characterized in that, adds adsorbent pin charcoal in step (2) back, and stirring at room adopts microporous filter membrane, titanium filter stick or sand filtration rod filtering decarbonization.
6. injection neo-houttuyninum sodium freeze-dried powder injection preparation method as claimed in claim 4 is characterized in that, filters at step (3) solution and adopts 0.22～0.45 μ m microporous filter membrane fine straining, and filtrate is carried out packing by every 0.5ml～10ml.
7. injection neo-houttuyninum sodium freeze-dried powder injection preparation method as claimed in claim 4, it is characterized in that, freezing method in step (4) is as follows: per minute reduces by 10 ℃～15 ℃, cool to-30 ℃ to-50 ℃ until solution, kept 2 hours～8 hours, and heated again to-20 ℃ to-35 ℃.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 03112411 CN1209104C (en) | 2003-06-10 | 2003-06-10 | Neohouttuynin sodium freeze-dried powder-injection, and its prepn. method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 03112411 CN1209104C (en) | 2003-06-10 | 2003-06-10 | Neohouttuynin sodium freeze-dried powder-injection, and its prepn. method |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1459284A true CN1459284A (en) | 2003-12-03 |
| CN1209104C CN1209104C (en) | 2005-07-06 |
Family
ID=29430236
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 03112411 Expired - Fee Related CN1209104C (en) | 2003-06-10 | 2003-06-10 | Neohouttuynin sodium freeze-dried powder-injection, and its prepn. method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1209104C (en) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1297260C (en) * | 2004-01-20 | 2007-01-31 | 昆明紫健生物技术有限公司 | Fatty acyl acetaldehyde powder projection and its preparing method |
| CN100336519C (en) * | 2005-10-07 | 2007-09-12 | 邹巧根 | Snakegourd peel lyophilized powder injection and its preparation process |
| CN100336523C (en) * | 2005-10-07 | 2007-09-12 | 邹巧根 | Rhubarb lyophilized injection and preparation method thereof |
| CN100417416C (en) * | 2006-03-07 | 2008-09-10 | 中国药科大学 | Medicine composition containing neohouttuynin sodium and solutol HS15 |
| CN102846563A (en) * | 2012-10-10 | 2013-01-02 | 德州德药制药有限公司 | Injection composition of pemetrexed disodium and preparation method of injection composition |
| CN103265459A (en) * | 2013-06-03 | 2013-08-28 | 四川省惠达药业有限公司 | Novel sodium houttuyfonate compound as well as preparation method and pharmaceutical composition thereof |
-
2003
- 2003-06-10 CN CN 03112411 patent/CN1209104C/en not_active Expired - Fee Related
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1297260C (en) * | 2004-01-20 | 2007-01-31 | 昆明紫健生物技术有限公司 | Fatty acyl acetaldehyde powder projection and its preparing method |
| CN100336519C (en) * | 2005-10-07 | 2007-09-12 | 邹巧根 | Snakegourd peel lyophilized powder injection and its preparation process |
| CN100336523C (en) * | 2005-10-07 | 2007-09-12 | 邹巧根 | Rhubarb lyophilized injection and preparation method thereof |
| CN100417416C (en) * | 2006-03-07 | 2008-09-10 | 中国药科大学 | Medicine composition containing neohouttuynin sodium and solutol HS15 |
| CN102846563A (en) * | 2012-10-10 | 2013-01-02 | 德州德药制药有限公司 | Injection composition of pemetrexed disodium and preparation method of injection composition |
| CN102846563B (en) * | 2012-10-10 | 2014-10-08 | 德州德药制药有限公司 | Injection composition of pemetrexed disodium and preparation method of injection composition |
| CN103265459A (en) * | 2013-06-03 | 2013-08-28 | 四川省惠达药业有限公司 | Novel sodium houttuyfonate compound as well as preparation method and pharmaceutical composition thereof |
| CN103265459B (en) * | 2013-06-03 | 2015-09-09 | 四川省惠达药业有限公司 | A kind of novel sodium houttuyfonate compound, its preparation method and pharmaceutical composition thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1209104C (en) | 2005-07-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1298386C (en) | Prepn process of slow release parathyroid hormone microballoon | |
| JPH07285853A (en) | Preparation of a micro particle | |
| MXPA03002543A (en) | Process for producing nanoparticles of paclitaxel and albumin. | |
| IL194656A (en) | Lyophilized formulation comprising a nicotine-virus-like particle conjugate | |
| CN1209104C (en) | Neohouttuynin sodium freeze-dried powder-injection, and its prepn. method | |
| CN105078905A (en) | Preparation method of doxycycline hyclate freeze-dried powder injection | |
| CN1469734A (en) | Pharmaceutical form of administration for peptides, method for its production and use | |
| CN1868459A (en) | Docetaxel freeze-dried powder-injection, and its prepn. method | |
| CN1259041C (en) | Bromhexine Hydrochloride aseptic freeze-drying formulation for injection and its preparation method | |
| CN115400225A (en) | Ligand-bound gold clusters, compositions and methods for treating liver cirrhosis | |
| CN1572296A (en) | Freeze dried vinpocetine powder injection and its preparation process | |
| CN1679542A (en) | Frozen powder injection of silybin and its preparing method | |
| CN102058548A (en) | Ambroxol hydrochloride composition for injection and preparation method thereof | |
| CN109820820B (en) | Alprostadil injection and preparation method thereof | |
| CN1526399A (en) | Diammonium glycyrrhizinate freeze drying powder for injection and its prepn | |
| CN109044980B (en) | Somatostatin freeze-dried powder injection pharmaceutical composition and preparation method thereof | |
| CN1230175C (en) | Ligustrazine hydrochloride freeze-dried preparation for injection and its preparing method | |
| CN1615867A (en) | Naloxone hydrchloride freeze-dried powder preparation for injection | |
| CN1853726A (en) | Polymer system for improving insoluble medicine water solubility and preparation thereof | |
| CN1074278C (en) | Preparation of bacteria-free freezing-dried prostaglandin E1 powder injection | |
| CN1183908C (en) | Injection medication combination of nimodipine and its preparing method | |
| CN1070053C (en) | Method for preparing butethanol of injection | |
| CN1561985A (en) | Novel sodium houttuyfonate powder injection | |
| CN1739796A (en) | Slow release parathyroid hormone microballoon | |
| CN114276563B (en) | Preparation method of medical hydrogel, hydrogel and dressing |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C57 | Notification of unclear or unknown address | ||
| DD01 | Delivery of document by public notice |
Addressee: Ning Qinliang Document name: Notice of conformity |
|
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |